aTYR PHARMA INC - COMMON STOCK (ATYR)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
97,996,626
Total 13F shares
20,534,388
Share change
+621,400
Total reported value
$153,393,033
Put/Call ratio
102%
Price per share
$7.47
Number of holders
45
Value change
+$3,923,414
Number of buys
23
Number of sells
20

Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2021

As of 31 Dec 2021 aTYR PHARMA INC - COMMON STOCK (ATYR) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 20,534,388 shares of stock of the company.
Largest 10 holders included FEDERATED HERMES, INC., FMR LLC, VR Adviser, LLC, Tikvah Management LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Deep Track Capital, LP, Alyeska Investment Group, L.P., BAKER BROS. ADVISORS LP, and Stonepine Capital Management, LLC.
This table shows 45 institutional shareholders of the security as of 31 Dec 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.